


Oncology
2023-04-21

Both allogenic and xenogenic GvHD models were able to simulate clinical GvHD symptoms. Both models responded to known anti-GvHD drugs effectively and showed evident improvement of GvHD after treatment.
Taken together, the two GvHD models we have developed show great potential for preclinical evaluation of anti-GvHD drugs. They can be used for studying the pathophysiology of GvHD.
More infomation about blogs

Let us know which event you're attending and we'd be happy to connect with you.
This website will store cookies on your computer. These cookies are used to collect information about how you interact with this website and enable us to remember you. We use this information to improve and customize your browsing experience, as well as to analyze and collect relevant data and metrics about visitors on this website and other platforms. For more information about the cookies we use, please refer to our privacy policy
If you decline, your information will not be tracked when visiting this website. A cookie will be used in your browser to remember your preference settings that you have not accepted.
